STOCK TITAN

[Form 4] ORACLE CORP Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Oracle (ORCL) Form 4: Company officer Mark Hura, Pres., Global Field Operations, reported a grant of stock options on 10/23/2025. The award covers 428,465 options with an exercise price of $280.07 per share and an expiration date of 10/23/2035.

Following the grant, 428,465 derivative securities are beneficially owned, held directly. The options vest 25% each year on the anniversary of the grant date.

Oracle (ORCL) Modulo 4: Un dirigente dell'azienda, Mark Hura, Presidente, Global Field Operations, ha riportato una concessione di stock option il 23/10/2025. L'assegnazione copre 428.465 opzioni con un prezzo di esercizio di $280,07 per azione e una data di scadenza del 23/10/2035.

Dopo la concessione, 428.465 strumenti derivati sono di diritto di beneficiare, detenuti direttamente. Le opzioni maturano 25% all'anno nel giorno dell'anniversario della data di concessione.

Oracle (ORCL) Formulario 4: El funcionario de la empresa Mark Hura, Presidente, Operaciones Globales de Campo, informó sobre una concesión de opciones sobre acciones el 23/10/2025. La adjudicación cubre 428,465 opciones con un precio de ejercicio de $280.07 por acción y una fecha de vencimiento de 23/10/2035.

Tras la concesión, 428,465 valores derivados son propiedad beneficiosa, mantenidos directamente. Las opciones vencen 25% cada año en el aniversario de la fecha de concesión.

Oracle (ORCL) Form 4: 회사 임원 Mark Hura, 사장, 글로벌 현장 운영팀, 2025년 10월 23일 주식 옵션 부여를 보고했습니다. 이 상은 428,465개의 옵션으로 행사 가격은 주당 $280.07이며 만료 날짜는 2035년 10월 23일입니다.

부여 이후 428,465개의 파생 증권이 직접 보유되며, 옵션은 부여일의 기념일로부터 매년 25%씩 귀속됩니다.

Oracle (ORCL) Formulaire 4 : Le cadre de l'entreprise Mark Hura, Président, Global Field Operations, a signalé une attribution d'options d'achat d'actions le 23/10/2025. La récompense couvre 428 465 options avec un prix d'exercice de $280,07 par action et une date d'expiration du 23/10/2035.

Suite à l'attribution, 428 465 instruments dérivés sont détenus bénéficiaires directement. Les options se libèrent à raison de 25% chaque année à la date anniversaire de la date d'attribution.

Oracle (ORCL) Formular 4: Unternehmensbeauftragter Mark Hura, Präsident, Global Field Operations, meldete am 23.10.2025 eine Gewährung von Aktienoptionen. Die Zuweisung umfasst 428.465 Optionen mit einem Ausübungspreis von $280,07 pro Aktie und einem Ablaufdatum des 23.10.2035.

Nach der Gewährung sind 428.465 derivative Werte direkt im Eigentum. Die Optionen vesten 25% pro Jahr am Jahrestag des Gewährungsdatums.

Oracle (ORCL) نموذج 4: أبلغ مسؤول الشركة Mark Hura، الرئيس، العمليات الميدانية العالمية، عن منح خيارات أسهم في 23/10/2025. يغطي الإسناد 428,465 خياراً بسعر ممارسة قدره $280.07 للسهم وتاريخ انتهاء 23/10/2035.

بعد المنحة، تكون 428,465 أدوات مشتقة مملوكة للمستفيد بشكل مباشر. تتفكك صلاحية الخيارات بمعدل 25% كل عام في ذكرى تاريخ المنحة.

Positive
  • None.
Negative
  • None.

Oracle (ORCL) Modulo 4: Un dirigente dell'azienda, Mark Hura, Presidente, Global Field Operations, ha riportato una concessione di stock option il 23/10/2025. L'assegnazione copre 428.465 opzioni con un prezzo di esercizio di $280,07 per azione e una data di scadenza del 23/10/2035.

Dopo la concessione, 428.465 strumenti derivati sono di diritto di beneficiare, detenuti direttamente. Le opzioni maturano 25% all'anno nel giorno dell'anniversario della data di concessione.

Oracle (ORCL) Formulario 4: El funcionario de la empresa Mark Hura, Presidente, Operaciones Globales de Campo, informó sobre una concesión de opciones sobre acciones el 23/10/2025. La adjudicación cubre 428,465 opciones con un precio de ejercicio de $280.07 por acción y una fecha de vencimiento de 23/10/2035.

Tras la concesión, 428,465 valores derivados son propiedad beneficiosa, mantenidos directamente. Las opciones vencen 25% cada año en el aniversario de la fecha de concesión.

Oracle (ORCL) Form 4: 회사 임원 Mark Hura, 사장, 글로벌 현장 운영팀, 2025년 10월 23일 주식 옵션 부여를 보고했습니다. 이 상은 428,465개의 옵션으로 행사 가격은 주당 $280.07이며 만료 날짜는 2035년 10월 23일입니다.

부여 이후 428,465개의 파생 증권이 직접 보유되며, 옵션은 부여일의 기념일로부터 매년 25%씩 귀속됩니다.

Oracle (ORCL) Formulaire 4 : Le cadre de l'entreprise Mark Hura, Président, Global Field Operations, a signalé une attribution d'options d'achat d'actions le 23/10/2025. La récompense couvre 428 465 options avec un prix d'exercice de $280,07 par action et une date d'expiration du 23/10/2035.

Suite à l'attribution, 428 465 instruments dérivés sont détenus bénéficiaires directement. Les options se libèrent à raison de 25% chaque année à la date anniversaire de la date d'attribution.

Oracle (ORCL) Formular 4: Unternehmensbeauftragter Mark Hura, Präsident, Global Field Operations, meldete am 23.10.2025 eine Gewährung von Aktienoptionen. Die Zuweisung umfasst 428.465 Optionen mit einem Ausübungspreis von $280,07 pro Aktie und einem Ablaufdatum des 23.10.2035.

Nach der Gewährung sind 428.465 derivative Werte direkt im Eigentum. Die Optionen vesten 25% pro Jahr am Jahrestag des Gewährungsdatums.

Oracle (ORCL) نموذج 4: أبلغ مسؤول الشركة Mark Hura، الرئيس، العمليات الميدانية العالمية، عن منح خيارات أسهم في 23/10/2025. يغطي الإسناد 428,465 خياراً بسعر ممارسة قدره $280.07 للسهم وتاريخ انتهاء 23/10/2035.

بعد المنحة، تكون 428,465 أدوات مشتقة مملوكة للمستفيد بشكل مباشر. تتفكك صلاحية الخيارات بمعدل 25% كل عام في ذكرى تاريخ المنحة.

Oracle (ORCL) 表格4: 公司高管 Mark Hura,总裁,全球现场运营,报告于2025/10/23 授予股票期权。该授予涵盖 428,465 份期权,行权价为每股 $280.07,到期日为 2035/10/23

在授予之后,428,465 项衍生证券为受益所有,直接持有。期权在授予日周年日的 每年 25% 归属(解锁)。

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hura Mark

(Last) (First) (Middle)
C/O DELPHI ASSET MGMT CORPORATION
200 S. VIRGINIA ST., SUITE 625

(Street)
RENO NV 89501

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ORACLE CORP [ ORCL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Pres., Global Field Operations
3. Date of Earliest Transaction (Month/Day/Year)
10/23/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option $280.07 10/23/2025 A 428,465 (1) 10/23/2035 Common Stock 428,465 $0 428,465 D
Explanation of Responses:
1. 25% of the shares subject to the option vest annually on each anniversary of the grant date.
s/ Aimee Weast by Aimee Weast, Attorney in Fact for Mark Hura (POA filed10/1/2025) 10/27/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Oracle Corp

NYSE:ORCL

ORCL Rankings

ORCL Latest News

ORCL Latest SEC Filings

ORCL Stock Data

732.34B
1.68B
41.55%
45.19%
0.76%
Software - Infrastructure
Services-prepackaged Software
Link
United States
AUSTIN